Freedom Day Solutions, LLC Biogen Inc. Transaction History

Freedom Day Solutions, LLC

  • $293 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$236.26 - $355.63 $946,457 - $1.42 Million
-4,006 Closed
0 $0
Q3 2020

Oct 26, 2020
SELL
$264.77 - $305.71 $20,652 - $23,845
-78 Reduced 1.91%
4,006 $1.14 Million
Q2 2020

Jul 27, 2020
BUY
$258.66 - $342.55 $367,814 - $487,106
1,422 Added 53.42%
4,084 $1.09 Million
Q1 2020

Apr 10, 2020
BUY
$268.85 - $341.04 $715,678 - $907,848
2,662 New
2,662 $842,000

Others Institutions Holding BIIB

# of Institutions
1,050
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $27.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Freedom Day Solutions, LLC Portfolio

Follow Freedom Day Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Day Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email